147 related articles for article (PubMed ID: 22027577)
1. Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice.
Nguyen K; D'Mello C; Le T; Urbanski S; Swain MG
J Hepatol; 2012 Mar; 56(3):626-31. PubMed ID: 22027577
[TBL] [Abstract][Full Text] [Related]
2. Kupffer cells abrogate cholestatic liver injury in mice.
Gehring S; Dickson EM; San Martin ME; van Rooijen N; Papa EF; Harty MW; Tracy TF; Gregory SH
Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
[TBL] [Abstract][Full Text] [Related]
3. Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.
D'Mello C; Almishri W; Liu H; Swain MG
Gastroenterology; 2017 Nov; 153(5):1416-1428.e2. PubMed ID: 28802564
[TBL] [Abstract][Full Text] [Related]
4. Cholestatic interleukin-6-deficient mice succumb to endotoxin-induced liver injury and pulmonary inflammation.
Sewnath ME; van der Poll T; van Noorden CJ; ten Kate FJ; Gouma DJ
Am J Respir Crit Care Med; 2004 Feb; 169(3):413-20. PubMed ID: 14604838
[TBL] [Abstract][Full Text] [Related]
5. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
Almishri W; Swain LA; D'Mello C; Le TS; Urbanski SJ; Nguyen HH
Front Immunol; 2021; 12():779119. PubMed ID: 35095853
[TBL] [Abstract][Full Text] [Related]
6. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
7. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice.
Mingam R; Moranis A; Bluthé RM; De Smedt-Peyrusse V; Kelley KW; Guesnet P; Lavialle M; Dantzer R; Layé S
Eur J Neurosci; 2008 Nov; 28(9):1877-86. PubMed ID: 18973601
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice.
Kerfoot SM; D'Mello C; Nguyen H; Ajuebor MN; Kubes P; Le T; Swain MG
Hepatology; 2006 Jan; 43(1):154-62. PubMed ID: 16374849
[TBL] [Abstract][Full Text] [Related]
11. NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism.
Cheng CW; Duwaerts CC; Rooijen Nv; Wintermeyer P; Mott S; Gregory SH
J Hepatol; 2011 Apr; 54(4):746-52. PubMed ID: 21129806
[TBL] [Abstract][Full Text] [Related]
12. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice.
Abe T; Arai T; Ogawa A; Hiromatsu T; Masuda A; Matsuguchi T; Nimura Y; Yoshikai Y
Hepatology; 2004 Aug; 40(2):414-23. PubMed ID: 15368446
[TBL] [Abstract][Full Text] [Related]
13. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
15. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
16. Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver.
Kloek JJ; Marsman HA; van Vliet AK; Gouma DJ; van Gulik TM
Surgery; 2008 Jul; 144(1):22-31. PubMed ID: 18571581
[TBL] [Abstract][Full Text] [Related]
17. Excessive inflammation but decreased immunological response renders liver susceptible to infection in bile duct ligated mice.
Morita Y; Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Takeuchi D; Mitsuhashi N; Iida A; Miyazaki M
J Surg Res; 2008 May; 146(2):262-70. PubMed ID: 18061617
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis.
Kawarabayashi N; Seki S; Hatsuse K; Kinoshita M; Takigawa T; Tsujimoto H; Kawabata T; Nakashima H; Shono S; Mochizuki H
Shock; 2010 May; 33(5):500-6. PubMed ID: 19823116
[TBL] [Abstract][Full Text] [Related]
19. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling.
Xiao Y; Wang J; Yan W; Zhou Y; Chen Y; Zhou K; Wen J; Wang Y; Cai W
J Hepatol; 2015 Apr; 62(4):889-96. PubMed ID: 25450715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
